The novel findings of our research are as follows: i) CYP2J2 inhibits HRVEC viability and angiogenesis in a hypoxia-induced retinopathy model; ii) the effects of CYP2J2 on hypoxia-induced HRVEC are regulated via the Notch signaling pathway. Here, CYP2J2 is linked to retinal disorder.